178 related articles for article (PubMed ID: 27221375)
1. The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors.
Wiczling P; Bartkowska-Śniatkowska A; Szerkus O; Siluk D; Rosada-Kurasińska J; Warzybok J; Borsuk A; Kaliszan R; Grześkowiak E; Bienert A
J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):315-24. PubMed ID: 27221375
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
3. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
Tse AHW; Ling L; Lee A; Joynt GM
Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.
Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F
Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.
Iirola T; Aantaa R; Laitio R; Kentala E; Lahtinen M; Wighton A; Garratt C; Ahtola-Sätilä T; Olkkola KT
Crit Care; 2011; 15(5):R257. PubMed ID: 22030215
[TBL] [Abstract][Full Text] [Related]
6. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study.
Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW
Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects.
Lee S; Kim BH; Lim K; Stalker D; Wisemandle W; Shin SG; Jang IJ; Yu KS
J Clin Pharm Ther; 2012 Dec; 37(6):698-703. PubMed ID: 22650799
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Effects of Continuous Dexmedetomidine Infusion Without a Loading Dose in the Pediatric Intensive Care Unit.
Cummings BM; Cowl AS; Yager PH; El Saleeby CM; Shank ES; Noviski N
J Intensive Care Med; 2015 Dec; 30(8):512-7. PubMed ID: 24923492
[TBL] [Abstract][Full Text] [Related]
9. Effect of dexmedetomidine on its clearance: a pharmacokinetic model.
Pypendop BH; Escobar A; Siao KT; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2013 Feb; 36(1):89-91. PubMed ID: 22292938
[No Abstract] [Full Text] [Related]
10. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients.
Iirola T; Ihmsen H; Laitio R; Kentala E; Aantaa R; Kurvinen JP; Scheinin M; Schwilden H; Schüttler J; Olkkola KT
Br J Anaesth; 2012 Mar; 108(3):460-8. PubMed ID: 22277665
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.
Liu HC; Lian QQ; Wu FF; Wang CY; Sun W; Zheng LD; Schüttler J; Ihmsen H
Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):201-211. PubMed ID: 27037817
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of dexmedetomidine in postsurgical pediatric intensive care unit patients: preliminary study.
Díaz SM; Rodarte A; Foley J; Capparelli EV
Pediatr Crit Care Med; 2007 Sep; 8(5):419-24. PubMed ID: 17693909
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients.
Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A
J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine disposition in children: a population analysis.
Potts AL; Warman GR; Anderson BJ
Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Children Undergoing Ambulatory Surgery.
Pérez-Guillé MG; Toledo-López A; Rivera-Espinosa L; Alemon-Medina R; Murata C; Lares-Asseff I; Chávez-Pacheco JL; Gómez-Garduño J; Zamora Gutiérrez AL; Orozco-Galicia C; Ramírez-Morales K; Lugo-Goytia G
Anesth Analg; 2018 Sep; 127(3):716-723. PubMed ID: 29782406
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.
Zhong W; Zhang Y; Zhang MZ; Huang XH; Li Y; Li R; Liu QW
J Clin Pharm Ther; 2018 Jun; 43(3):414-421. PubMed ID: 29247451
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.
Zimmerman KO; Wu H; Laughon M; Greenberg RG; Walczak R; Schulman SR; Smith PB; Hornik CP; Cohen-Wolkowiez M; Watt KM
Anesth Analg; 2019 Dec; 129(6):1519-1528. PubMed ID: 31743171
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients.
Smuszkiewicz P; Wiczling P; Ber J; Warzybok J; Małkiewicz T; Matysiak J; Klupczyńska A; Trojanowska I; Kokot Z; Grześkowiak E; Krzyzanski W; Bienert A
J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):277-284. PubMed ID: 29290034
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age.
Vilo S; Rautiainen P; Kaisti K; Aantaa R; Scheinin M; Manner T; Olkkola KT
Br J Anaesth; 2008 May; 100(5):697-700. PubMed ID: 18378546
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
Knibbe CA; Zuideveld KP; DeJongh J; Kuks PF; Aarts LP; Danhof M
Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
